Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19
Wells CR, Pandey A, Gokcebel S, Krieger G, Donoghue AM, Singer BH, Moghadas SM, Galvani AP, Townsend JP. Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19. PNAS Nexus 2022, 1: pgac100. PMID: 35909795, PMCID: PMC9335027, DOI: 10.1093/pnasnexus/pgac100.Peer-Reviewed Original ResearchSARS-CoV-2Serial testingSerial testing strategyHigh population immunityQuarantine durationBenefits of vaccinationSARS-CoV-2 variantsDisease time courseCOVID-19CoV-2 variantsPublic health toolVaccine boostingThird doseVaccination statusVaccination coveragePopulation immunityCoV-2Health toolsDisease control effortsInfected casesLocal transmissionInfectiousness profileVaccinationTime courseImmunityQuarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study
Wells CR, Pandey A, Fitzpatrick MC, Crystal WS, Singer BH, Moghadas SM, Galvani AP, Townsend JP. Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study. The Lancet Regional Health - Europe 2022, 14: 100304. PMID: 35036981, PMCID: PMC8743228, DOI: 10.1016/j.lanepe.2021.100304.Peer-Reviewed Original ResearchShorter quarantineContacts of casesQuarantine durationCOVID-19 infectionLarge socioeconomic burdenCOVID-19 pandemicRisk stratificationSocioeconomic burdenInfection rateRT-PCRThree daysCanadian InstitutePandemic diseaseNational InstituteHealth researchLonger quarantineEpidemic situationTesting strategies